相关临床试验
0
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
暂无批准数据
- The Barbara Ann Karmanos Cancer Institute will hold its fifth annual Screening Saves Lives event on Saturday, Oct. 3, 2026, from 9 a.m. to 1 p.m. at Karmanos Cancer Center in Detroit. - The event offers both insurance-based screenings (colonoscopy prep, low-dose CT lung screening, mammogram) and free walk-in screenings including head and neck, skin cancer, and wellness checks. - According to Metropolitan Detroit Cancer Surveillance System data, over 416 per 100,000 Detroit residents are diagnosed with cancer, with breast, lung, and colorectal cancers showing the highest incidence. - Early detection expands treatment options, and the event connects eligible women to free breast and cervical screenings through the Tri-County Breast & Cervical Cancer Control Program.
- The National Cancer Institute awarded Wayne State University's Heather Gibson, Ph.D., a five-year, $3.1 million R01 grant to find more effective treatment strategies for HER2+ breast cancer. - The project focuses on host-intrinsic genetic mechanisms regulating immune activation after targeted immunotherapy, particularly trastuzumab (Herceptin), which binds HER2 overexpressed in roughly 20% of breast cancers. - Only about 50% of metastatic HER2+ breast cancers respond to trastuzumab, and the research aims to identify genes that influence immune activation to improve long-term outcomes. - Positive results could lead to new drug combinations or cellular therapies that enhance anti-tumor immunity, potentially extending benefits beyond trastuzumab to other therapies.
